These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25131433)

  • 21. ATP-P2X4 signaling mediates NLRP3 inflammasome activation: a novel pathway of diabetic nephropathy.
    Chen K; Zhang J; Zhang W; Zhang J; Yang J; Li K; He Y
    Int J Biochem Cell Biol; 2013 May; 45(5):932-43. PubMed ID: 23434541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reactive oxygen species activated NLRP3 inflammasomes initiate inflammation in hyperosmolarity stressed human corneal epithelial cells and environment-induced dry eye patients.
    Zheng Q; Ren Y; Reinach PS; Xiao B; Lu H; Zhu Y; Qu J; Chen W
    Exp Eye Res; 2015 May; 134():133-40. PubMed ID: 25701684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NLRP3 and ASC differentially affect the lung transcriptome during pneumococcal pneumonia.
    van Lieshout MH; Scicluna BP; Florquin S; van der Poll T
    Am J Respir Cell Mol Biol; 2014 Apr; 50(4):699-712. PubMed ID: 24164497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated expression of the NLRP3 inflammasome in neutrophilic asthma.
    Simpson JL; Phipps S; Baines KJ; Oreo KM; Gunawardhana L; Gibson PG
    Eur Respir J; 2014 Apr; 43(4):1067-76. PubMed ID: 24136334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation.
    Zhang X; Zhang JH; Chen XY; Hu QH; Wang MX; Jin R; Zhang QY; Wang W; Wang R; Kang LL; Li JS; Li M; Pan Y; Huang JJ; Kong LD
    Antioxid Redox Signal; 2015 Apr; 22(10):848-70. PubMed ID: 25602171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder.
    Alcocer-Gómez E; de Miguel M; Casas-Barquero N; Núñez-Vasco J; Sánchez-Alcazar JA; Fernández-Rodríguez A; Cordero MD
    Brain Behav Immun; 2014 Feb; 36():111-7. PubMed ID: 24513871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease.
    Zhou Y; Lu M; Du RH; Qiao C; Jiang CY; Zhang KZ; Ding JH; Hu G
    Mol Neurodegener; 2016 Apr; 11():28. PubMed ID: 27084336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rituximab-induced interstitial lung disease: case report and literature review.
    Zayen A; Rais H; Rifi H; Ouarda M; Afrit M; Cherif A; Mezline A
    Pharmacology; 2011; 87(5-6):318-20. PubMed ID: 21613805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model.
    Luo B; Li B; Wang W; Liu X; Liu X; Xia Y; Zhang C; Zhang Y; Zhang M; An F
    Cardiovasc Drugs Ther; 2014 Feb; 28(1):33-43. PubMed ID: 24254031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tripartite-motif protein 30 negatively regulates NLRP3 inflammasome activation by modulating reactive oxygen species production.
    Hu Y; Mao K; Zeng Y; Chen S; Tao Z; Yang C; Sun S; Wu X; Meng G; Sun B
    J Immunol; 2010 Dec; 185(12):7699-705. PubMed ID: 21048113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemin inhibits NLRP3 inflammasome activation in sepsis-induced acute lung injury, involving heme oxygenase-1.
    Luo YP; Jiang L; Kang K; Fei DS; Meng XL; Nan CC; Pan SH; Zhao MR; Zhao MY
    Int Immunopharmacol; 2014 May; 20(1):24-32. PubMed ID: 24583148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The NLRP3 inflammasome affects DNA damage responses after oxidative and genotoxic stress in dendritic cells.
    Licandro G; Ling Khor H; Beretta O; Lai J; Derks H; Laudisi F; Conforti-Andreoni C; Liang Qian H; Teng GG; Ricciardi-Castagnoli P; Mortellaro A
    Eur J Immunol; 2013 Aug; 43(8):2126-37. PubMed ID: 23619996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of NLRP3 inflammasome, cytokines and vascular mediators in the skin of systemic sclerosis patients.
    Martínez-Godínez MA; Cruz-Domínguez MP; Jara LJ; Domínguez-López A; Jarillo-Luna RA; Vera-Lastra O; Montes-Cortes DH; Campos-Rodríguez R; López-Sánchez DM; Mejía-Barradas CM; Castelán-Chávez EE; Miliar-García A
    Isr Med Assoc J; 2015 Jan; 17(1):5-10. PubMed ID: 25739168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Procyanidin B2 inhibits NLRP3 inflammasome activation in human vascular endothelial cells.
    Yang H; Xiao L; Yuan Y; Luo X; Jiang M; Ni J; Wang N
    Biochem Pharmacol; 2014 Dec; 92(4):599-606. PubMed ID: 25450671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The nucleotide-binding domain and leucine-rich repeat protein-3 inflammasome is not activated in airway smooth muscle upon toll-like receptor-2 ligation.
    Hirota JA; Im H; Rahman MM; Rumzhum NN; Manetsch M; Pascoe CD; Bunge K; Alkhouri H; Oliver BG; Ammit AJ
    Am J Respir Cell Mol Biol; 2013 Oct; 49(4):517-24. PubMed ID: 23614732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesenchymal stem/stromal cells inhibit the NLRP3 inflammasome by decreasing mitochondrial reactive oxygen species.
    Oh JY; Ko JH; Lee HJ; Yu JM; Choi H; Kim MK; Wee WR; Prockop DJ
    Stem Cells; 2014 Jun; 32(6):1553-63. PubMed ID: 24307525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylsulfonylmethane inhibits NLRP3 inflammasome activation.
    Ahn H; Kim J; Lee MJ; Kim YJ; Cho YW; Lee GS
    Cytokine; 2015 Feb; 71(2):223-31. PubMed ID: 25461402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deregulated NLRP3 and NLRP1 inflammasomes and their correlations with disease activity in systemic lupus erythematosus.
    Yang Q; Yu C; Yang Z; Wei Q; Mu K; Zhang Y; Zhao W; Wang X; Huai W; Han L
    J Rheumatol; 2014 Mar; 41(3):444-52. PubMed ID: 24334646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Rituximab-induced interstitial lung disease].
    Fernández Casares M; Espósito G; González A; Segovia J; Galperín Mde L; Del Valle E
    Medicina (B Aires); 2013; 73(4):343-5. PubMed ID: 23924535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rituximab therapy for refractory interstitial lung disease related to antisynthetase syndrome.
    Marie I; Dominique S; Janvresse A; Levesque H; Menard JF
    Respir Med; 2012 Apr; 106(4):581-7. PubMed ID: 22280877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.